Literature DB >> 15115667

Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension.

Sunil K Nadar1, Eman Al Yemeni, Andrew D Blann, Gregory Y H Lip.   

Abstract

OBJECTIVE: Endothelial disturbance (whether activation, dysfunction or damage) is a likely pathogenic mechanism in pre-eclampsia and pregnancy-induced hypertension (PIH). We set out to determine which of three plasma markers of endothelial disturbance, indicating endothelial activation (E-selectin) or damage/dysfunction (von Willebrand factor (vWf), soluble thrombomodulin), would provide the best discriminator of PIH compared to normotensive pregnancy. STUDY
DESIGN: Cross-sectional study of 36 consecutive women with PIH (age 31+/-6 years) and 36 consecutive women with normotensive pregnancies (age 29+/-5 years) of similar parity. Plasma levels of vWf, E-selectin and thrombomodulin were measured using ELISA.
RESULTS: As expected, women with PIH had significantly higher levels of plasma vWf (by 19%, p=0.003), E-selectin (by 40%, p<0.001) and thrombomodulin (by 61%, p=0.01) than normotensive women. However, on stepwise multiple regression analysis, only thrombomodulin was an independent significant predictor of the presence of PIH (p=0.023).
CONCLUSIONS: We conclude that although vWf, E-selectin and thrombomodulin are all raised in PIH, only thrombomodulin was independently associated with PIH. This molecule could potentially be useful in monitoring and in providing clues in aetiology and pathophysiology, and may have implications for the clinical complications associated with PIH.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15115667     DOI: 10.1016/j.thromres.2004.02.010

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  9 in total

1.  Activated platelets induce Weibel-Palade-body secretion and leukocyte rolling in vivo: role of P-selectin.

Authors:  Vandana S Dole; Wolfgang Bergmeier; Heather A Mitchell; Sarah C Eichenberger; Denisa D Wagner
Journal:  Blood       Date:  2005-06-14       Impact factor: 22.113

2.  Endothelial dysfunction in hypertension in pregnancy: associations between circulating endothelial cells, circulating progenitor cells and plasma von Willebrand factor.

Authors:  V J Karthikeyan; Andrew D Blann; Sabah Baghdadi; Deirdre A Lane; D Gareth Beevers; Gregory Y H Lip
Journal:  Clin Res Cardiol       Date:  2011-01-09       Impact factor: 5.460

3.  Immunohistochemical expression of von Willebrand factor in the preeclamptic placenta.

Authors:  Mauro Parra-Cordero; Cleofina Bosco; Jaime González; Rodrigo Gutiérrez; Pilar Barja; Ramón Rodrigo
Journal:  J Mol Histol       Date:  2011-08-17       Impact factor: 2.611

4.  Von Willebrand factor, red cell fragmentation, and disease activity in systemic lupus erythematosus.

Authors:  Rodolfo V Curiel; Rajkumari Bhagati; Lakshmi Basavaraju; Delona Norton; James Katz; Elizabeth Haile; Arthur Weinstein
Journal:  HSS J       Date:  2008-07-01

5.  Von Willebrand factor, ADAMTS13 activity, TNF-α and their relationships in patients with chronic kidney disease.

Authors:  Lei Shen; Guoyuan Lu; Ningzheng Dong; Liqiong Jiang; Zhenni Ma; Changgeng Ruan
Journal:  Exp Ther Med       Date:  2011-12-23       Impact factor: 2.447

6.  Preeclampsia serum upregulates CD40/CD40L expression and induces apoptosis in human umbilical cord endothelial cells.

Authors:  Chun-feng Wu; Fu-dan Huang; Ren-fang Sui; Jing-xia Sun
Journal:  Reprod Biol Endocrinol       Date:  2012-04-18       Impact factor: 5.211

7.  Soluble FLT1 sensitizes endothelial cells to inflammatory cytokines by antagonizing VEGF receptor-mediated signalling.

Authors:  Tereza Cindrova-Davies; Deborah A Sanders; Graham J Burton; D Stephen Charnock-Jones
Journal:  Cardiovasc Res       Date:  2010-12-07       Impact factor: 10.787

8.  Donkin psychosis.

Authors:  Ian Brockington
Journal:  Arch Womens Ment Health       Date:  2016-10-08       Impact factor: 3.633

9.  A novel role of kallikrein-related peptidase 8 in the pathogenesis of diabetic cardiac fibrosis.

Authors:  Jian-Kui Du; Qing Yu; Yu-Jian Liu; Shu-Fang Du; Li-Yang Huang; Dan-Hong Xu; Xin Ni; Xiao-Yan Zhu
Journal:  Theranostics       Date:  2021-02-20       Impact factor: 11.556

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.